Average Co-Inventor Count = 4.67
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cephalon, Inc. (19 from 247 patents)
2. Ignyta, Inc. (5 from 25 patents)
3. Cephalon France (2 from 20 patents)
24 patents:
1. 10017496 - Uracil derivatives as AXL and c-MET kinase inhibitors
2. 9745283 - Uracil derivatives as AXL and c-MET kinase inhibitors
3. 9522902 - Uracil derivatives as AXL and c-MET kinase inhibitors
4. 9120778 - Uracil derivatives as AXL and c-MET kinase inhibitors
5. 9029538 - Uracil derivatives as AXL and c-MET kinase inhibitors
6. 8765779 - Tricyclic derivatives and their pharmaceutical use and compositions
7. 8552186 - Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors
8. 8471005 - Pyrrolotriazines as ALK and JAK2 inhibitors
9. 8153667 - Tricyclic aromatic and bis-phenyl sulfinyl derivatives
10. 8148391 - Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors
11. 8071604 - Thio-substituted arylmethanesulfinyl derivatives
12. 7314875 - Tricyclic aromatic and bis-phenyl sulfinyl derivatives
13. 7297817 - Thio-substituted arylmethanesulfinyl derivatives
14. 7288650 - Cyclic substituted fused pyrrolocarbazoles and isoindolones
15. 7074793 - Cyclic substituted fused pyrrolocarbazoles and isoindolones